content

Cytiva launches exosome manufacturing challenge to advance next-generation therapies

Cytiva launches the โ€œExosome Challenge,โ€ an industry challenge to overcome hurdles in exosome production and manufacturing. The challenge will focus on the standard workflow,...

Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab

Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumabโ„ข, Humanigenโ€™s therapeutic...

US FDA grants breakthrough therapy designation to Novartis STAMP inhibitor asciminib to treat chronic myeloid leukemia

Novartis announced that asciminib, a novel investigational treatment specifically targeting the ABL myristoyl pocket (STAMP), has been granted Breakthrough Therapy designation (BTD) by the...

Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform

Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVIDโ€“19 HT Kit that is compatible with the...

Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research

Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable, high-quality cryopreserved Leukopaks. The frozen Leukopaks will enable long-distance...

India developing 7 more indigenous Covid-19 vaccines

Union health minister Harsh Vardhan has said that the country is developing seven more Covid-19 vaccines to make them available to every citizen of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read